HIV-AIDS Testing Market by End-users and Geography - Global Forecast and Analysis 2019-2023

HIV・エイズ検査の世界市場予測・分析2019-2023

◆タイトル:HIV-AIDS Testing Market by End-users and Geography - Global Forecast and Analysis 2019-2023
◆商品コード:IRTNTR32016
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2019年9月28日
◆ページ数:144
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥265,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥318,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥424,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社の本調査レポートでは、HIV・エイズ検査の世界市場について調べ、HIV・エイズ検査の市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、HIV・エイズ検査の市場規模をセグメンテーション別(エンドユーザー別(診断検査室、病院、その他)、)と地域別(グローバル)に分けて算出しました。Technavio社はHIV・エイズ検査の世界市場規模が2019-2023期間中に年平均10%成長すると予測しています。
・サマリー
・レポートの範囲
・HIV・エイズ検査の市場状況
・HIV・エイズ検査の市場規模
・HIV・エイズ検査の市場予測
・HIV・エイズ検査の世界環境:ファイブフォース分析
・市場セグメンテーション:エンドユーザー別(診断検査室、病院、その他)
・HIV・エイズ検査の顧客状況
・主要地域別市場規模:グローバル
・意思決定フレームワーク
・市場動向・成長要因・課題
・関連企業状況・企業分析
 ...

Global HIV-AIDS Testing Market: About this market
Technavio’s HIV-AIDS testing market analysis considers sales from diagnostic laboratories, hospitals, and other end-users. Our analysis also considers the sales of HIV-AIDS testing in Asia, Europe, North America, and ROW. In 2018, the diagnostic laboratories segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as increasing investments in the development of HIV testing laboratory infrastructure will play a significant role in the diagnostic laboratories segment to maintain its market position. Also, our global HIV-AIDS testing market report looks at factors such as the increasing prevalence of HIV infections, growing awareness for early detection of HIV infection, and government support for HIV research and favorable recommendations on HIV testing. However, regional diversity in HIV strains hampers diagnostic capabilities, limited infrastructure in developing regions, and social stigma and ethical implication associated to clinical HIV testing may hamper the growth of the HIV-AIDS testing industry over the forecast period.
Global HIV-AIDS Testing Market: Overview
Government support for HIV research and favorable recommendations on HIV testing
The significant burden of HIV-AIDS has been a major concern for governments worldwide. To reduce the spread of HIV infections, governments are focusing on establishing efficient healthcare infrastructure for timely detection and treatment of HIV infections. Government allocates significant resources to increase the reach of HIV-AIDS programs and services. Federal funding is provided through direct grants, cooperative agreements, and contracts to support HIV awareness, treatment, and prevention. Such growth in funding helped promote the development of advanced HIV-AIDS testing products and increase the adoption of HIV-AIDS testing products among individuals in respective regions. Also, favorable recommendations by government authorities such as the CDC have surged the adoption of routine HIV-AIDS testing among adults, adolescents, and pregnant women. Such factors will lead to the expansion of the global HIV-AIDS testing market at a CAGR of over 10% during the forecast period.
Growing access to fourth-generation testing products
The commercial availability of fourth-generation tests for HIV has been a result of continuous efforts by market vendors in the development of advanced and early detection technologies for HIV testing. The detection of both antibodies and antigen allows fourth-generation tests to identify the presence of HIV infection sooner and with greater accuracy than conventional processes. The windows period of fourth-generation test is about 25% shorter than the third-generation HIV tests and about 50% shorter than the second-generation HIV tests. This allows healthcare providers and clinicians to offer early and timely treatments to slow down the further progression of the disease. This development is expected to have a positive impact on the overall market growth.
For the detailed list of factors that will drive the global HIV-AIDS testing market during the forecast period 2019-2023, click here.
Competitive Landscape
With the presence of a few major players, the global HIV-AIDS testing market is concentrated. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading HIV-AIDS testing manufacturers, that include Abbott Laboratories, Becton Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, and Siemens Healthineers AG.
Also, the HIV-AIDS testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

【資料の目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY END-USER
• Market segmentation by end-user
• Comparison by end-user
• Diagnostic laboratories – Market size and forecast 2018-2023
• Hospitals – Market size and forecast 2018-2023
• Others – Market size and forecast 2018-2023
• Market opportunity by end-user
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Growing adoption of POC testing products
• Growing access to fourth-generation testing products
• Decreasing prices of HIV tests
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott Laboratories
• Becton Dickinson and Co.
• bioMérieux SA
• Bio-Rad Laboratories Inc.
• Danaher Corp.
• F. Hoffmann-La Roche Ltd.
• OraSure Technologies Inc.
• PerkinElmer Inc.
• QIAGEN NV
• Siemens Healthineers AG
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Product overview
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: End-user – Market share 2018-2023 (%)
Exhibit 19: Comparison by end-user
Exhibit 20: Diagnostic laboratories – Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Diagnostic laboratories – Year-over-year growth 2019-2023 (%)
Exhibit 22: Hospitals – Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Hospitals – Year-over-year growth 2019-2023 (%)
Exhibit 24: Others – Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Others – Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by end-user
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2018-2023 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 31: North America – Year-over-year growth 2019-2023 (%)
Exhibit 32: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 34: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 36: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 37: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Abbott Laboratories – Vendor overview
Exhibit 47: Abbott Laboratories – Business segments
Exhibit 48: Abbott Laboratories – Organizational developments
Exhibit 49: Abbott Laboratories – Geographic focus
Exhibit 50: Abbott Laboratories – Segment focus
Exhibit 51: Abbott Laboratories – Key offerings
Exhibit 52: Becton Dickinson and Co. – Vendor overview
Exhibit 53: Becton Dickinson and Co. – Business segments
Exhibit 54: Becton Dickinson and Co. – Organizational developments
Exhibit 55: Becton Dickinson and Co. – Geographic focus
Exhibit 56: Becton Dickinson and Co. – Segment focus
Exhibit 57: Becton Dickinson and Co. – Key offerings
Exhibit 58: bioMérieux SA – Vendor overview
Exhibit 59: bioMérieux SA – Business segments
Exhibit 60: bioMérieux SA – Organizational developments
Exhibit 61: bioMérieux SA – Geographic focus
Exhibit 62: bioMérieux SA – Key offerings
Exhibit 63: Bio-Rad Laboratories Inc. – Vendor overview
Exhibit 64: Bio-Rad Laboratories Inc. – Business segments
Exhibit 65: Bio-Rad Laboratories Inc. – Organizational developments
Exhibit 66: Bio-Rad Laboratories Inc. – Geographic focus
Exhibit 67: Bio-Rad Laboratories Inc. – Segment focus
Exhibit 68: Bio-Rad Laboratories Inc. – Key offerings
Exhibit 69: Danaher Corp. – Vendor overview
Exhibit 70: Danaher Corp. – Business segments
Exhibit 71: Danaher Corp. – Organizational developments
Exhibit 72: Danaher Corp. – Geographic focus
Exhibit 73: Danaher Corp. – Segment focus
Exhibit 74: Danaher Corp. – Key offerings
Exhibit 75: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 76: F. Hoffmann-La Roche Ltd. – Business segments
Exhibit 77: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 78: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 79: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 80: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 81: OraSure Technologies Inc. – Vendor overview
Exhibit 82: OraSure Technologies Inc. – Business segments
Exhibit 83: OraSure Technologies Inc. – Organizational developments
Exhibit 84: OraSure Technologies Inc. – Geographic focus
Exhibit 85: OraSure Technologies Inc. – Segment focus
Exhibit 86: OraSure Technologies Inc. – Key offerings
Exhibit 87: PerkinElmer Inc. – Vendor overview
Exhibit 88: PerkinElmer Inc. – Business segments
Exhibit 89: PerkinElmer Inc. – Organizational developments
Exhibit 90: PerkinElmer Inc. – Geographic focus
Exhibit 91: PerkinElmer Inc. – Segment focus
Exhibit 92: PerkinElmer Inc. – Key offerings
Exhibit 93: QIAGEN NV – Vendor overview
Exhibit 94: QIAGEN NV – Product segments
Exhibit 95: QIAGEN NV – Organizational developments
Exhibit 96: QIAGEN NV – Geographic focus
Exhibit 97: QIAGEN NV – Segment focus
Exhibit 98: QIAGEN NV – Key offerings
Exhibit 99: Siemens Healthineers AG – Vendor overview
Exhibit 100: Siemens Healthineers AG – Business segments
Exhibit 101: Siemens Healthineers AG – Organizational developments
Exhibit 102: Siemens Healthineers AG – Geographic focus
Exhibit 103: Siemens Healthineers AG – Segment focus
Exhibit 104: Siemens Healthineers AG – Key offerings
Exhibit 105: Validation techniques employed for market sizing
Exhibit 106: Definition of market positioning of vendors



【掲載企業】

Abbott Laboratories, Becton Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, and Siemens Healthineers AG.

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[HIV・エイズ検査の世界市場予測・分析2019-2023]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆